EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Financial toxicity of cancer treatment in India: towards closing the cancer care gap

Shankar Prinja, Jyoti Dixit, Nidhi Gupta, Anushikha Dhankhar, Amal Chandra Kataki, Partha Sarathi Roy, Nikita Mehra, Lalit Kumar, Ashish Singh, Pankaj Malhotra, Aarti Goyal, Kavitha Rajsekar und 2 weitere

Frontiers in Public Health · 19.06.2023 · 11

DOI: 10.3389/fpubh.2023.1065737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 19.06.2023. Verfasst von Shankar Prinja und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Financial Stress, Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known about its prevalence and determinants among the Indian population. There is a need to determine the optimal strategy for clinicians and cancer care centers to address the issue of high costs of care in order to minimize the financial toxicity, promote access to high value care and reduce health disparities.

Methods

A total of 12,148 cancer patients were recruited at seven purposively selected cancer centres in India, to assess the out-of-pocket expenditure (OOPE) and financial toxicity among cancer patients. Mean OOPE incurred for outpatient treatment and hospitalization, was estimated by cancer site, stage, type of treatment and socio-demographic characteristics. Economic impact of cancer care on household financial risk protection was assessed using standard indicators of catastrophic health expenditures (CHE) and impoverishment, along with the determinants using logistic regression.

Results

Mean direct OOPE per outpatient consultation and per episode of hospitalization was estimated as ₹8,053 (US$ 101) and ₹39,085 (US$ 492) respectively. Per patient annual direct OOPE incurred on cancer treatment was estimated as ₹331,177 (US$ 4,171). Diagnostics (36.4%) and medicines (45%) are major contributors of OOPE for outpatient treatment and hospitalization, respectively. The overall prevalence of CHE and impoverishment was higher among patients seeking outpatient treatment (80.4% and 67%, respectively) than hospitalization (29.8% and 17.2%, respectively). The odds of incurring CHE was 7.4 times higher among poorer patients [Adjusted Odds Ratio (AOR): 7.414] than richest. Enrolment in PM-JAY (CHE AOR = 0.426, and impoverishment AOR = 0.395) or a state sponsored scheme (CHE AOR = 0.304 and impoverishment AOR = 0.371) resulted in a significant reduction in CHE and impoverishment for an episode of hospitalization. The prevalence of CHE and impoverishment was significantly higher with hospitalization in private hospitals and longer duration of hospital stay ( p < 0.001). The extent of CHE and impoverishment due to direct costs incurred on outpatient treatment increased from 83% to 99.7% and, 63.9% to 97.1% after considering both direct and indirect costs borne by the patient and caregivers, respectively. In case of hospitalization, the extent of CHE increased from 23.6% (direct cost) to 59.4% (direct+ indirect costs) and impoverishment increased from 14.1% (direct cost) to 27% due to both direct and indirect cost of cancer treatment.

Conclusion

There is high economic burden on patients and their families due to cancer treatment. The increase in population and cancer services coverage of PFHI schemes, creating prepayment mechanisms like E-RUPI for outpatient diagnostic and staging services, and strengthening public hospitals can potentially reduce the financial burden among cancer patients in India. The disaggregated OOPE estimates could be useful input for future health technology analyses to determine cost-effective treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Financial StressNeoplasmsHumansHospitalizationHealth ExpendituresInsurance, HealthFamily Characteristics

Stichwörter der Autor:innen

cancercatastrophic health expendituredirect out of pocket expenditurefinancial toxicityhospitalizationimpoverishmentindirect cost due to loss of productivityoutpatient care

Autor:innen und Institutionen

  • Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India.
  • Dr. B. Booroah Cancer Institute, Guwahati, India.
  • Department of Medical Oncology, Adyar Cancer Institute, Chennai, India.
  • Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Medical Oncology, Christian Medical College, Vellore, India.

Zitieren

APA

Prinja, S., Dixit, J., Gupta, N., Dhankhar, A., Kataki, A. C., Roy, P. S., Mehra, N., Kumar, L., Singh, A., Malhotra, P., Goyal, A., Rajsekar, K., Krishnamurthy, M. N., & Gupta, S. (2023). Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1065737

Vancouver

Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, et al. Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health. 2023;11. doi:10.3389/fpubh.2023.1065737

BibTeX
@article{Prinja2023,
  author = {Prinja, Shankar and Dixit, Jyoti and Gupta, Nidhi and Dhankhar, Anushikha and Kataki, Amal Chandra and Roy, Partha Sarathi and Mehra, Nikita and Kumar, Lalit and Singh, Ashish and Malhotra, Pankaj and Goyal, Aarti and Rajsekar, Kavitha and Krishnamurthy, Manjunath Nookala and Gupta, Sudeep},
  title = {Financial toxicity of cancer treatment in India: towards closing the cancer care gap},
  journal = {Frontiers in Public Health},
  year = {2023},
  volume = {11},
  doi = {10.3389/fpubh.2023.1065737}
}
Kostenlos starten →